Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers

International Journal of Cancer

Volumn 121, Issue 12, 2007, Pages 2748-2752

  Randi, Giorgia ^a   Pelucchi, Claudio ^a   Negri, Eva ^a   Talamini, Renato ^b   Galeone, Carlotta ^a   Franceschi, Silvia ^c   La Vecchia, Carlo ^a,d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Case control study; Family history; Urogenital cancer

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLADDER CANCER; BODY MASS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; KIDNEY CANCER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL RECORD; PRIORITY JOURNAL; PROSTATE CANCER; UROGENITAL TRACT CANCER;

ADULT; AGED; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; ITALY; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS; UROGENITAL NEOPLASMS;

EID: 36249026453     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23037     Document Type: Article

References (46)

1. Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Bladder cancer risk as modified by family history and smoking. Cancer 2006;107:705-11.
2. Negri E, Pelucchi C, Talamini R, Montella M, Gallus S, Bosetti C, Franceschi S, La Vecchia C. Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int J Cancer 2005;114:648-52.
3. Negri E, Foschi R, Talamini R, Montella M, Ramazzotti V, Dal Maso L, Bosetti C, Franceschi S, Zucchetto A, La Vecchia C. Family history of cancer and the risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2441-4.
4. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 2006;3:327-40.
5. Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell carcinoma. Int J Cancer 2002;98:274-8.
6. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
7. Plna K, Hemminki K. Familial bladder cancer in the National Swedish Family Cancer Database. J Urol 2001;166:2129-33.
8. Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Family history and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2001;10:1001-4.
9. Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history. Cancer Causes Control 1994;5:105-13.
10. Schlehofer B, Pommer W, Mellemgaard A, Stewart JH, McCredie M, Niwa S, Lindblad P, Mandel JS, McLaughlin JK, Wahrendorf J. International renal-cell-cancer study. Vl. The role of medical and family history. Int J Cancer 1996;66:723-6.
11. Czene K, Hemminki K. Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies. Kidney Int 2002;61:1806-13.
12. Gudbjartsson T, Jonasdottir TJ, Thoroddsen A, Einarsson GV, Jonsdottir GM, Kristjansson K, Hardarson S, Magnusson K, Gulcher J, Stefansson K, Amundadottir LT. A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas. Int J Cancer 2002;100:476-9.
13. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
14. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 2003;107:797-803.
15. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003;91:789-94.
16. Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H. Familial risk of prostate cancer in Iceland. BJU Int 2003;92:915-9.
17. Gronberg H, Bergh A, Damber JE, Emanuelsson M. Cancer risk in families with hereditary prostate carcinoma. Cancer 2000;89:1315-21.
18. D'Avanzo B, La Vecchia C, Franceschi S, Negri E, Talamini R, Buttino I. Coffee consumption and bladder cancer risk. Eur J Cancer 1992;28A:1480-4.
19. D'Avanzo B, Negri E, La Vecchia C, Gramenzi A, Bianchi C, Franceschi S, Boyle P. Cigarette smoking and bladder cancer. Eur J Cancer 1990;26:714-8.
20. Talamini R, Baron AE, Barra S, Bidoli E, La Vecchia C, Negri E, Serraino D, Franceschi S. A case-control study of risk factor for renal cell cancer in northern Italy. Cancer Causes Control 1990;1:125-31.
21. Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E. Diet and prostatic cancer: a case-control study in northern Italy. Nutr Cancer 1992;18:277-86.
22. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - the analysis of case-control studies. IARC Sci Publ 1980:5-338.
23. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-14.
24. Mezzetti M, Ferraroni M, Decarli A, La Vecchia C, Benichou J. Software for attributable risk and confidence interval estimation in case-control studies. Comput Biomed Res 1996;29:63-75.
25. D'Avanzo B, La Vecchia C, Negri E, Decarli A, Benichou J. Attributable risks for bladder cancer in northern Italy. Ann Epidemiol 1995;5:427-31.
26. La Vecchia C, Negri E, D'Avanzo B, Franceschi S. Occupation and the risk of bladder cancer. Int J Epidemiol 1990;19:264-8.
27. La Vecchia C, Negri E, D'Avanzo B, Franceschi S. Smoking and renal cell carcinoma. Cancer Res 1990;50:5231-3.
28. La Vecchia C, Franceschi S, Talamini R, Negri E, Boyle P, D'Avanzo B. Marital status, indicators of sexual activity and prostatic cancer. J Epidemiol Community Health 1993;47:450-3.
29. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004;292:1480-9.
30. Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO. Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 2006;98:61-8.
31. Bravi F, Bosetti C, Negri E, Lagiou P, La Vecchia C. Family history of cancer provided by hospital controls was satisfactorily reliable. J Clin Epidemiol 2007;60:171-5.
32. Kramer AA, Graham S, Burnett WS, Nasca P. Familial aggregation of bladder cancer stratified by smoking status. Epidemiology 1991;2:145-8.
33. Hemminki K, Vaittinen P, Dong C, Easton D. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 2001;84:388-91.
34. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995;1:827-9.
35. Pakkanen S, Baffoe-Bonnie AB, Matikainen MP, Koivisto PA, Tammela TL, Deshmukh S, Ou L, Bailey-Wilson JE, Schleutker J. Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Hum Genet 2007;121:257-67.
36. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskem D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20:175-9.
37. Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004; 13 Spec No 1:R103-21.
38. Cancer risks in BRCA2 mutation carriers.The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310-6.
39. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-5.
40. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003;72:1-12.
41. Iliopoulos O, Eng C. Genetic and clinical aspects of familial renal neoplasms. Semin Oncol 2000;27:138-49.
42. Pavlovich CP, Schmidt LS. Searching for the hereditary causes of renal-cell carcinoma. Nat Rev Cancer 2004;4:381-93.
43. Peto J, Houlston RS. Genetics and the common cancers. Eur J Cancer 2001;37 Suppl 8:S88-S96.
44. Hemminki K, Li X. Familial renal cell cancer appears to have a recessive component. J Med Genet 2004;41:e58.
45. Hemminki R, Czene R. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002;11:1638-44.
46. Tavani A, Pregnolato A, Violante A, La Vecchia C, Negri E. Attributable risks for kidney cancer in northern Italy. Eur J Cancer Prev 1997;6:195-9.